1. Home
  2. BYND vs CRDF Comparison

BYND vs CRDF Comparison

Compare BYND & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BYND
  • CRDF
  • Stock Information
  • Founded
  • BYND 2009
  • CRDF 1999
  • Country
  • BYND United States
  • CRDF United States
  • Employees
  • BYND N/A
  • CRDF N/A
  • Industry
  • BYND Packaged Foods
  • CRDF Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BYND Consumer Staples
  • CRDF Health Care
  • Exchange
  • BYND Nasdaq
  • CRDF Nasdaq
  • Market Cap
  • BYND 296.7M
  • CRDF 240.2M
  • IPO Year
  • BYND 2019
  • CRDF N/A
  • Fundamental
  • Price
  • BYND $4.00
  • CRDF $3.52
  • Analyst Decision
  • BYND Sell
  • CRDF Strong Buy
  • Analyst Count
  • BYND 6
  • CRDF 3
  • Target Price
  • BYND $5.50
  • CRDF $10.33
  • AVG Volume (30 Days)
  • BYND 4.1M
  • CRDF 1.2M
  • Earning Date
  • BYND 02-25-2025
  • CRDF 02-27-2025
  • Dividend Yield
  • BYND N/A
  • CRDF N/A
  • EPS Growth
  • BYND N/A
  • CRDF N/A
  • EPS
  • BYND N/A
  • CRDF N/A
  • Revenue
  • BYND $323,473,000.00
  • CRDF $688,000.00
  • Revenue This Year
  • BYND N/A
  • CRDF $25.03
  • Revenue Next Year
  • BYND $3.70
  • CRDF N/A
  • P/E Ratio
  • BYND N/A
  • CRDF N/A
  • Revenue Growth
  • BYND N/A
  • CRDF 49.57
  • 52 Week Low
  • BYND $3.30
  • CRDF $1.44
  • 52 Week High
  • BYND $12.12
  • CRDF $6.42
  • Technical
  • Relative Strength Index (RSI)
  • BYND 49.41
  • CRDF 46.40
  • Support Level
  • BYND $3.50
  • CRDF $3.33
  • Resistance Level
  • BYND $4.22
  • CRDF $4.89
  • Average True Range (ATR)
  • BYND 0.25
  • CRDF 0.29
  • MACD
  • BYND 0.09
  • CRDF -0.13
  • Stochastic Oscillator
  • BYND 72.15
  • CRDF 14.91

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels, and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").

Share on Social Networks: